Jacobs Levy Equity Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,933
| Closed | -$15K | – | 998 |
|
|
2018
Q2 | $15K | Sell |
1,933
-15,074
| -89% | -$117K | ﹤0.01% | 1011 |
|
|
2018
Q1 | $594K | Buy |
17,007
+4,234
| +33% | +$148K | 0.01% | 750 |
|
|
2017
Q4 | $544K | Buy |
12,773
+5,026
| +65% | +$214K | 0.01% | 735 |
|
|
2017
Q3 | $332K | Buy |
7,747
+1,967
| +34% | +$84.3K | 0.01% | 772 |
|
|
2017
Q2 | $214K | Buy |
5,780
+1,673
| +41% | +$61.9K | ﹤0.01% | 824 |
|
|
2017
Q1 | $222K | Buy |
+4,107
| New | +$222K | ﹤0.01% | 773 |
|
|
2016
Q3 | – | Sell |
-9,127
| Closed | -$601K | – | 1026 |
|
|
2016
Q2 | $601K | Sell |
9,127
-53
| -0.6% | -$3.49K | 0.01% | 707 |
|
|
2016
Q1 | $521K | Buy |
+9,180
| New | +$521K | 0.01% | 715 |
|